Generic Drug Sponsors Would Get More Info On Brand Inactive Ingredients Under User Fee Bill

 
• By Derrick Gingery
drug ingredient
Generic drug sponsors would know whether their inactive ingredient guesses are right sooner under a provision in the House FDA user fee reauthorization bill. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics